Drugs / [68Ga]CBP8
Trials 6 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03535545 | Aug 2018 → Jun 2027 expected | lung cancer, pulmonary fibrosis | Massachusetts General Hospital | Recruiting | No outcome recorded |
| Phase 24 trials | ||||||
| Phase 2 | NCT07572383 | May 2026 → Dec 2028 expected | pulmonary fibrosis | Peter Caravan | Recruiting | No outcome recorded |
| Phase 2 | NCT06532071 | Jan 2025 → Dec 2028 expected | pulmonary fibrosis | Peter Caravan | Recruiting | No outcome recorded |
| Phase 2 | NCT05417776 | Sep 2022 → Oct 2026 expected | interstitial lung disease | Massachusetts General Hospital | Recruiting | No outcome recorded |
| Phase 2 | NCT04485286 | Jul 2020 → May 2027 expected | drug or radiation exposure-related interstitial lung disease, lung cancer, malignant pancreatic neoplasm | Massachusetts General Hospital | Recruiting | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT05619302 | Jan 2023 → Dec 2026 expected | amyloidosis | Brigham and Women's Hospital | Active not recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 68Ga-CBP8 | “The human analog probe targeted against type 1 collagen, 68Ga-CBP8, was tested on excised human lung tissue containing RILI and quantified via autoradiography.” PMID 37808864 ↗ Sep 20237“The 68Ga-Collagen Binding Probe #8, 68Ga-CBP8, is a peptide-based, type I collagen-targeted probe developed for imaging of tissue fibrosis.” PMID 37116909 ↗ Dec 2022 |
| Known as | 68Ga-Collagen Binding Probe #8 | “The 68Ga-Collagen Binding Probe #8, 68Ga-CBP8, is a peptide-based, type I collagen-targeted probe developed for imaging of tissue fibrosis.” PMID 37116909 ↗ Dec 2022 |
| Modality | Diagnostic / imaging agent | “The 68Ga-Collagen Binding Probe #8, 68Ga-CBP8, is a peptide-based, type I collagen-targeted probe developed for imaging of tissue fibrosis.” PMID 37116909 ↗ Dec 2022 |
| Route | Intravenous | “will be administered intravenously” NCT05417776 ↗ |